Simulations Plus, Inc. (NASDAQ: SLP) is the premier developer of modeling & simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. We partner with companies to provide a data-driven, ‘strategic modeling methodology’, starting in early discovery, continuing through preclinical/clinical development, and concluding with clinical trials/post approval.
Simulations Plus technology is licensed to and used by regulatory agencies worldwide. For over 20 years, Simulations Plus has partnered with our clients to reduce costs and accelerate research and development productivity by improving the ways scientists use knowledge and data to predict the properties and outcomes of pharmaceutical & biotechnology agents. Simulations Plus’ team of over 90 dedicated scientists & professionals, with decades of experience, stands ready to help.
Stop by to talk to us in booth #1027 at the AAPS PharmSci360 Annual Meeting in Washington DC November 4th-7th. Our "invite-only" annual User Forum is on November 6th to request your invitation please email Renee Bouche at email@example.com